Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,1641927,Alcrsp10,Alcohol response QTL 10,,,alcohol metabolism trait (VT:0015089),blood ethanol level (CMO:0000535),11,9351274,54351274,Rat,n/a,region,qtl 1000,1300147,Bp187,Blood pressure QTL 187,3.67,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),11,1,72720192,Rat,n/a,region,qtl 1000,1598811,Bp291,Blood pressure QTL 291,1.9,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),11,21944229,66944229,Rat,n/a,region,qtl 1000,10755497,Bp388,Blood pressure QTL 388,2.76,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),11,19475179,79734728,Rat,n/a,region,qtl 1000,634341,Bw121,Body weight QTL 121,3.56,,abdominal fat pad mass (VT:1000711),abdominal fat pad weight (CMO:0000088),11,22043149,44444112,Rat,n/a,region,qtl 1000,8694376,Bw156,Body weight QTL 156,2.25,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),11,25720038,70720038,Rat,n/a,region,qtl 1000,8694424,Bw162,Body weight QTL 162,3.8,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),11,25720038,70720038,Rat,n/a,region,qtl 1000,9589032,Epfw10,Epididymal fat weight QTL 10,9.29,0.001,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),11,25720038,70720038,Rat,n/a,region,qtl 1000,10058952,Gmadr6,Adrenal mass QTL 6,2.29,0.0072,adrenal gland mass (VT:0010420),both adrenal glands wet weight to body weight ratio (CMO:0002411),11,25401129,70401129,Rat,n/a,region,qtl 1000,724554,Iddm17,Insulin dependent diabetes mellitus QTL 17,,0.001,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),11,19016272,90463843,Rat,n/a,region,qtl 1000,1598841,Memor7,Memory QTL 7,,,exploratory behavior trait (VT:0010471),total horizontal distance resulting from voluntary locomotion in an experimental apparatus (CMO:0001443),11,21944229,66944229,Rat,n/a,region,qtl 1000,2298551,Neuinf10,Neuroinflammation QTL 10,3.7,,nervous system integrity trait (VT:0010566),spinal cord beta-2 microglobulin mRNA level (CMO:0002125),11,32155520,82443118,Rat,n/a,region,qtl 1000,1300130,Rf20,Renal function QTL 20,4.44,,kidney glomerulus integrity trait (VT:0010546),kidney glomerulus diameter (CMO:0001166),11,30435339,63186373,Rat,n/a,region,qtl 1000,2290451,Scl58,Serum cholesterol level QTL 58,3.48,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),11,11367306,44444347,Rat,n/a,region,qtl 1000,9590313,Scort20,Serum corticosterone level QTL 20,6.51,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),11,25720038,70720038,Rat,n/a,region,qtl 1000,1300110,Stl7,Serum triglyceride level QTL 7,4.64,,blood triglyceride amount (VT:0002644),plasma triglyceride level (CMO:0000548),11,30435339,86714631,Rat,n/a,region,qtl 1000,1558659,Tescar1,Testicular tumor resistance QTL 1,3.9,,testis integrity trait (VT:0010572),percentage of study population developing testis tumors during a period of time (CMO:0001261),11,325031,69342559,Rat,n/a,region,qtl 1000,724563,Uae10,Urinary albumin excretion QTL 10,6,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),11,28314665,86994795,Rat,n/a,region,qtl 1000,724517,Uae18,Urinary albumin excretion QTL 18,3.7,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),11,16321973,46583360,Rat,n/a,region,qtl